PLK1 and breast carcinoma: The PLK1 inhibitor BI2536 enhances the effect of paclitaxel on MCF‐7 and T‐47D breast cancer cells, by inducing their apoptosis, whereas it prevents tamoxifen‐induced senescence [191].